Cargando…
Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis
Pharmacogenomic studies allowed the reasons behind the different responses to treatments to be understood. Its clinical utility, in fact, is demonstrated by the reduction in adverse drug reaction incidence and the improvement of drug efficacy. Pharmacogenomics is an important tool that is able to im...
Autores principales: | Caputo, Valerio, Strafella, Claudia, Cosio, Terenzio, Lanna, Caterina, Campione, Elena, Novelli, Giuseppe, Giardina, Emiliano, Cascella, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470543/ https://www.ncbi.nlm.nih.gov/pubmed/34573380 http://dx.doi.org/10.3390/genes12091398 |
Ejemplares similares
-
Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes
por: Caputo, Valerio, et al.
Publicado: (2020) -
RNAseq-Based Prioritization Revealed COL6A5, COL8A1, COL10A1 and MIR146A as Common and Differential Susceptibility Biomarkers for Psoriasis and Psoriatic Arthritis: Confirmation from Genotyping Analysis of 1417 Italian Subjects
por: Caputo, Valerio, et al.
Publicado: (2020) -
Experimental Pharmacological Management of Psoriasis
por: Campione, Elena, et al.
Publicado: (2021) -
Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes
por: Caputo, Valerio, et al.
Publicado: (2020) -
The Interplay between miRNA-Related Variants and Age-Related Macular Degeneration: EVIDENCE of Association of MIR146A and MIR27A
por: Strafella, Claudia, et al.
Publicado: (2019)